DuP 753, a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in rat striatum

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1992-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00165730PMID 1314959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.

  1993cited by this paper
• Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brain.

  1990cited by this paper
• Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).

  1990cited by this paper
• Glucocorticoid regulation of rat diencephalon angiotensinogen production.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• The brain angiotensin system: insights from mapping its components.

  1990cited by this paper
• Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonists.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Outflow and overflow of picogram levels of endogenous dopamine and DOPAC from rat striatal slices: improved methodology for studies of stimulus-evoked release and metabolism.

  1989cited by this paper
• Angiotensin‐Converting Enzyme in Rat Brain and Extraneural Tissues Visualized by Quantitative Autoradiography Using 3H‐Trandolaprilate

  1989cited by this paper
• The renin-angiotensin system in the rat brain

  1988cited by this paper
• Intrarenal effects of angiotensin II in renal artery stenosis.

  1987cited by this paper
• Intrarenal effects of angiotensin II in renal artery stenosis.

  1987cited by this paper
• Localization of preangiotensinogen messenger RNA sequences in the rat brain.

  1986cited by this paper
• Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.

  1986cited by this paper
• Distribution of [125I]angiotensin II binding sites in the rat brain: a quantitative autoradiographic study.

  1986cited by this paper
• Angiotensin II in Rat Brain Comigrates with Authentic Angiotensin II in High Pressure Liquid Chromatography

  1985cited by this paper
• Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.

  1985cited by this paper
• Autoradiographic visualization of angiotensin-converting enzyme in rat brain with [3H]captopril: localization to a striatonigral pathway.

  1984cited by this paper
• Levels of adenosine and adenine nucleotides in slices of rat hippocampus.

  1984influential reference
• Autoradiographic localization of angiotensin II receptors in rat brain.

  1984cited by this paper
• Neurogenic Actions of Angiotensin II

  1983cited by this paper
• Differential distribution of immunoreactive angiotensin and angiotensin-converting enzyme in rat brain.

  1982cited by this paper
• [Angiotensin II and nigostriatal system (author's transl)].

  1981cited by this paper
• Immunoreactivity for an angiotensin II-like peptide in the human brain.

  1981cited by this paper
• The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol

  1979cited by this paper
• Pharmacologic interruption of the renin-angiotensin system.

  1979cited by this paper
• Angiotensin in the brain.

  1978cited by this paper
• Local regulation of adrenergic neurotransmission.

  1977cited by this paper
• Regulation of noradrenaline release by presynaptic receptor systems.

  1977cited by this paper
• Distribution of angiotensin II receptors in rat brain.

  1977cited by this paper
• Angiotensin II binding to mammalian brain membranes.

  1976cited by this paper
• The relative importance of central nervous catecholaminergic and cholinergic mechanisms in drinking in response to antiotensin and other thirst stimuli.

  1975cited by this paper
• Penetration of angiotensin II into the brain.

  1971cited by this paper

• The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene

  2021cites this paper
• Fluid intake, what's dopamine got to do with it?

  2021cites this paper
• The Effect of Telmisartan, an angiotensin receptor blocker, on Alcohol Consumption and Alcohol-Induced Dopamine Release in the Nucleus Accumbens.

  2021cites this paper
• Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity

  2018cites this paper
• Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease

  2017cites this paper
• Psychiatry and Neuroscience Update - Vol. II

  2017influential citation
• Mechanisms Involved in Memory Processes: Alterations Induced by Psychostimulants—Targeting the Central AT1 Receptors

  2017cites this paper
• The Extent of Neuroadaptive Responses to Psychostimulants: Focus on Brain Angiotensin System

  2017cites this paper
• Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations

  2015cites this paper
• Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.

  2014cites this paper
• Brain renin-angiotensin system and dopaminergic cell vulnerability

  2014cites this paper
• Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.

  2013cites this paper
• The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.

  2013cites this paper
• Angiotensin II stimulates sympathetic neurotransmission to adipose tissue

  2013cites this paper
• Cocaine administration increases angiotensin I-converting enzyme (ACE) expression and activity in the rat striatum and frontal cortex.

  2012cites this paper
• Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum.

  2010cites this paper
• Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats.

  2008cites this paper
• Acute and chronic losartan administration: effect on angiotensin II content and modulation of [3H]norepinephrine release from rat interscapular brown adipose tissue

  2005cites this paper
• Evidence that angiotensin II enhances apomorphine-induced jaw movements via AT1 receptors in the ventrolateral striatum: studies by magnet-sensing system in freely moving rats.

  2004cites this paper
• Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension.

  2004cites this paper
• The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors.

  2001cites this paper
• The association study of DRD2, ACE and AGT gene polymorphisms and metamphetamine dependence.

  2001cites this paper
• The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease.

  2000cites this paper
• Inhibition of the angiotensin II Type 1 receptor by TCV-116: quantitation by in vitro autoradiography.

  1999cites this paper
• Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan.

  1998cites this paper
• Further evidence for interaction between angiotensin II and dopamine receptors (experiments on apomorphine stereotypy).

  1998cites this paper
• Upregulation of angiotensin II AT1 receptors in the mouse nucleus accumbens by chronic haloperidol treatment.

  1997cites this paper
• Angiotensin‐Converting Enzyme Modulates Dopamine Turnover in the Striatum

  1997cites this paper
• Effect of angiotensin II on striatal dopamine release in the spontaneous hypertensive rat.

  1997cites this paper
• Losartan influences behavioural effects of angiotensin II(3-7) in rats.

  1996cites this paper
• Interactions of angiotensin II with central dopamine.

  1996cites this paper
• Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo

  1996cites this paper
• The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects.

  1996cites this paper
• Losartan influences behavioural effects of angiotensin II in rats.

  1996cites this paper
• Influence of sarmesin on some dopamine-related types of behaviour

  1996cites this paper
• Intrastriatal angiotensin II induces turning behaviour in 6-hydroxydopamine lesioned rats.

  1995cites this paper
• Angiotensin II and its 3-7 fragment improve recognition but not spatial memory in rats.

  1995cites this paper
• Interactions of angiotensin II with central catecholamines.

  1995cites this paper
• BLOCKADE BY INTRAVENOUS LOSARTAN OF AT1 ANGIOTENSIN II RECEPTORS IN RAT BRAIN, KIDNEY AND ADRENALS DEMONSTRATED BY IN VITRO AUTORADIOGRAPHY

  1994cites this paper
• Distribution of angiotensin II receptor subtypes in the rabbit brain.

  1993cites this paper
• Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.

  1993cites this paper
• Localization of components of the renin-angiotensin system and site of action of inhibitors.

  1993cites this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cites this paper